Amendment: SEC Form SC 13G/A filed by agilon health inc.

9/10/24 10:47:52 AM ET

Misc Health and Biotechnology Services

Health Care

Get the next $AGL alert in real time by email

SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.3 AGILON HEALTH INC COMMON STOCK Cusip #00857U107 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #00857U107 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 28,153,797 Item 6: 0 Item 7: 28,156,051 Item 8: 0 Item 9: 28,156,051 Item 11: 6.842% Item 12: HC Cusip #00857U107 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 28,156,051 Item 8: 0 Item 9: 28,156,051 Item 11: 6.842% Item 12: IN Item 1(a). Name of Issuer: AGILON HEALTH INC Item 1(b). Address of Issuer's Principal Executive Offices: 6210 E HWY 290, Suite 450 Austin, TX 78723 US Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 00857U107 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 28,156,051 (b) Percent of Class: 6.842% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 28,156,051 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of AGILON HEALTH INC. No one other person's interest in the COMMON STOCK of AGILON HEALTH INC is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. September 9, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC * IA Strategic Advisers LLC IA * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on September 9, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of AGILON HEALTH INC at August 30, 2024. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.

Get the next $AGL alert in real time by email

Recent Analyst Ratings for

$AGL

Date	Price Target	Rating	Analyst
11/11/2024		Mkt Outperform → Mkt Perform	JMP Securities
11/8/2024		Outperform → Mkt Perform	William Blair
10/30/2024	$7.00 → $2.50	Neutral → Sell	Citigroup
10/2/2024	$3.00	Buy → Underperform	BofA Securities
5/30/2024	$6.00	Neutral	Robert W. Baird
4/22/2024	$6.00	Neutral	Citigroup
3/6/2024	$5.00	Underweight	Barclays
2/26/2024	$25.00 → $6.50	Buy → Hold	Jefferies

More analyst ratings

Amendment: SEC Form SC 13G/A filed by agilon health inc.

Chat with this insight

Recent Analyst Ratings for $AGL

$AGL Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

CEO & President Sell Steven bought $67,188 worth of shares (20,000 units at $3.36) (SEC Form 4)

Chief Accounting Officer Gertsch Timothy covered exercise/tax liability with 405 shares, decreasing direct ownership by 0.69% to 57,947 units (SEC Form 4)

Chief Financial Officer Schwaneke Jeffrey A. was granted 659,880 shares, increasing direct ownership by 1,030% to 723,930 units (SEC Form 4)

$AGL Financials

Live finance-specific insights

agilon health Reports Third Quarter 2024 Results

agilon health Sets Date to Report Third Quarter 2024 Financial Results

agilon health Reports Second Quarter 2024 Results

$AGL Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Agilon Health downgraded by JMP Securities

Agilon Health downgraded by William Blair

Agilon Health downgraded by Citigroup with a new price target

$AGL Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

CEO & President Sell Steven bought $67,188 worth of shares (20,000 units at $3.36) (SEC Form 4)

Kornitzer Benjamin bought 5,434 shares and covered exercise/tax liability with 1,883 shares, increasing direct ownership by 6% to 62,058 units (SEC Form 4)

Venkatachaliah Girish covered exercise/tax liability with 1,883 shares and bought 5,434 shares, increasing direct ownership by 10% to 39,950 units (SEC Form 4)

$AGL SEC Filings

agilon health inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 10-Q filed by agilon health inc.

agilon health inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

$AGL Leadership Updates

Live Leadership Updates

agilon health Appoints Karthik Rao, M.D., as Chief Medical Officer

agilon health Names Jeff Schwaneke New Chief Financial Officer

agilon health, inc. investors: Please contact the Portnoy Law Firm to recover your losses; May 28, 2024 deadline

$AGL Large Ownership Changes

This live feed shows all institutional transactions in real time.

$AGL Press Releases

Fastest customizable press release news feed in the world

$AGL Market Insights

Live Market Insights